NDC 63323-617 – Milrinone Lactate
Milrinone Lactate 1 mg/mL · Injection, Solution · Intravenous
Product NDC63323-617
Product details
- Brand name
- Milrinone Lactate
- Generic name
- Milrinone Lactate
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA075936
- Marketed since
- August 1, 2002
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phosphodiesterase 3 Inhibitor
Active ingredients
- Milrinone Lactate 1 mg/mL
Uses, dosage, side effects and warnings for Milrinone Lactate →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 63323-617-10 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-617-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-617-01) | Aug 1, 2002 |
| 63323-617-20 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-617-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-617-02) | Aug 1, 2002 |
| 63323-617-50 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-617-50) / 50 mL in 1 VIAL, SINGLE-DOSE | Aug 1, 2002 |
Other Milrinone Lactate products
- 72485-503 Milrinone Lactate 1 mg/mL · Injection, Solution · Armas Pharmaceuticals Inc.
- 72485-502 Milrinone Lactate 1 mg/mL · Injection, Solution · Armas Pharmaceuticals Inc.
- 72485-501 Milrinone Lactate 1 mg/mL · Injection, Solution · Armas Pharmaceuticals Inc.
- 65145-122 Milrinone Lactate 1 mg/mL · Injection, Solution · Caplin Steriles Limited
- 65145-121 Milrinone Lactate 1 mg/mL · Injection, Solution · Caplin Steriles Limited
- 65145-120 Milrinone Lactate 1 mg/mL · Injection, Solution · Caplin Steriles Limited
- 55150-287 Milrinone Lactate .2 mg/mL · Injection, Solution · Eugia US LLC
- 55150-288 Milrinone Lactate .2 mg/mL · Injection, Solution · Eugia US LLC
- 0143-9373 Milrinone Lactate 1 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9374 Milrinone Lactate 1 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9709 Milrinone Lactate 1 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9710 Milrinone Lactate 1 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.